About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDNA

The Impact of Metformin on the Outcome of Gouty Arthritis in a Cohort of Egyptian Gouty Patients.

NCT05332795•Menoufia University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Gouty Arthritis

Interventions

Metformin

Placebo

Locations

1

Egypt

Locations (1)

Dalia Salah Saif

Menoufia Governorate, MD, Egypt

Key Dates

Start Date

June 28, 2022

Primary Completion Date

December 31, 2023

Completion Date

February 20, 2024

Last Updated

March 27, 2024

Related Studies

RECRUITINGPhase 2

A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty of Plonmarlimab in Subjects With Acute Gouty Arthritis

NCT07453004

Acute Gouty Arthritis

RECRUITINGPhase 2

Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

NCT07116746

GoutGouty Arthritis+5 more

COMPLETEDPhase 1

A Bioequivalence Study of Two Different Dosage Form of Genakumab

NCT06451848

Gouty Arthritis (GA)

Treatment of Topical Ketorolac Gel in Acute Gouty Flare

NCT06273813

Acute Gouty ArthritisAcute Pain+1 more

COMPLETEDPhase 2

Long Term Study of Canakinumab (ACZ885) in Patients With Gout

NCT00927810

Gouty Arthritis

Sonographic Signs of Gouty Arthritis in a Cohort of Egyptian Patients: a Cross Sectional Multicenter Study

NCT04734093

Sonographic Signs of Gouty Arthritis in Diagnosed and Suspected Patients

View all related studies

Sponsors

Lead Sponsor

Menoufia University

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 27, 2024Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions